Prevalence of SARS-CoV-2 antibodies among Swiss hospital workers: Results of a prospective cohort study
- PMID: 33028454
- PMCID: PMC7582018
- DOI: 10.1017/ice.2020.1244
Prevalence of SARS-CoV-2 antibodies among Swiss hospital workers: Results of a prospective cohort study
Abstract
In this prospective cohort of 1,012 Swiss hospital employees, 3 different assays were used to screen serum for SARS-CoV-2 antibodies. Seropositivity was 1%; the positive predictive values of the lateral-flow immunoassay were 64% (IgG) and 13% (IgM). History of fever and myalgia most effectively differentiated seropositive and seronegative participants.
Conflict of interest statement
All authors report no conflicts of interest relevant to this article.
Figures
References
-
- Adams JG, Walls RM. Supporting the health care workforce during the COVID-19 global epidemic. JAMA 2020;323:1439–1440. - PubMed
-
- Woloshin S, Patel N, Kesselheim AS. False negative tests for SARS-CoV-2 infection—challenges and implications. N Engl J Med 2020;383(6):e38. - PubMed
-
- Weinstein MC, Freedberg KA, Hyle EP, Paltiel AD. Waiting for certainty on COVID-19 antibody tests—at what cost? N Engl J Med 2020;383(6):e37. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
